EVALUATION OF A HETEROLOGOUS PRIME-BOOST VACCINE SCHEDULE BASED ON LOW SEROPREVALENT ADENOVIRUS VECTORS FOR MALARIA

被引：0
|
作者：
Rodriguez, Ariane Rodriguez [1 ]
Gillissen, Gert [1 ]
Tax, Dennis [1 ]
Mintardjo, Ratna [1 ]
Kuipers, Harmjan [1 ]
Custers, Jerome [1 ]
Pau, Maria Grazia [1 ]
Kostense, Stefan [1 ]
Hendriks, Jenny [1 ]
ter Haak, Mariska [1 ]
Goudsmit, Jaap [1 ]
Radosevic, Katarina [1 ]
机构：
[1] Crucell, Leiden, Netherlands
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2009年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1033
引用
收藏
页码：297 / 298
页数：2
相关论文
共 50 条
  • [31] Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
    Chapman, Ros
    van Diepen, Michiel
    Douglass, Nicola
    Galant, Shireen
    Jaffer, Mohamed
    Margolin, Emmanuel
    Ximba, Phindile
    Hermanus, Tandile
    Moore, Penny L.
    Williamson, Anna-Lise
    VACCINES, 2021, 9 (11)
  • [32] A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice
    Fonseca, Jairo A.
    McCaffery, Jessica N.
    Kashentseva, Elena
    Singh, Balwan
    Dmitriev, Igor P.
    Curiel, David T.
    Moreno, Alberto
    VACCINE, 2017, 35 (24) : 3239 - 3248
  • [33] Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine
    Cai, Hui
    Shukla, Sourabh
    Wang, Chao
    Masarapu, Hema
    Steinmetz, Nicole F.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (16) : 6509 - 6518
  • [34] Safety and immunogenicity of prime-boost immunization of Kenyan adults with candidate malaria vaccines based on a chimpanzee Adenovirus and MVA
    Ogwang, C.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 43 - 43
  • [35] Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters
    Rababa'h, A. M.
    Abedalqader, N. N.
    Ababneh, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (23) : 7516 - 7525
  • [36] Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin
    Kant, Rajni
    Dwivedi, Gaurav
    Zaman, Kamran
    Sahay, Rima R.
    Sapkal, Gajanan
    Kaushal, Himanshu
    Nyayanit, Dimpal A.
    Yadav, Pragya D.
    Deshpande, Gururaj
    Singh, Rajeev
    Chaowdhary, Sandeep
    Gupta, Nivedita
    Kumar, Sanjay
    Abraham, Priya
    Panda, Samiran
    Bhargava, Balram
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (08)
  • [37] Adenovirus-based prime-boost immunization for rapid vaccination against anthrax
    McConnell, Michael J.
    Hanna, Philip C.
    Imperiale, Michael J.
    MOLECULAR THERAPY, 2007, 15 (01) : 203 - 210
  • [38] Heterologous prime-boost vaccine using antigen-loaded microparticles and adenovirus (encoding antigen) enhances cellular immune responses and antitumor activity
    Ellis, Alexis A.
    Geary, Sean M.
    Salem, Aliasger K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 638
  • [39] Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
    Draper, SJ
    Moore, AC
    Gilbert, SC
    Hill, AVS
    IMMUNOLOGY, 2005, 116 : 25 - 25
  • [40] Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques
    Michel P. M. Vierboom
    Agnes L. Chenine
    Patricia A. Darrah
    Richard A. W. Vervenne
    Charelle Boot
    Sam O. Hofman
    Claudia C. Sombroek
    Karin Dijkman
    Mohamed A. Khayum
    Marieke A. Stammes
    Krista G. Haanstra
    Chantal Hoffmann
    Doris Schmitt
    Nathalie Silvestre
    Alexander G. White
    H. Jacob Borish
    Robert A. Seder
    Nadia Ouaked
    Stephane Leung-Theung-Long
    Geneviève Inchauspé
    Ravi Anantha
    Mary Limbach
    Thomas G. Evans
    Danilo Casimiro
    Maria Lempicki
    Dominick J. Laddy
    Aurelio Bonavia
    Frank A. W. Verreck
    npj Vaccines, 5
12345